奈诺沙星是一种非氟喹诺酮类抗生素,正在进行临床试验。它具有与氟喹诺酮类药物相同的作用机制;它抑制DNA回旋酶,防止DNA合成、基因复制和细胞分裂。到2016年底,它已经以Taigexyn的品牌在台湾、俄罗斯、英联邦独立国家、土耳其、中国大陆和拉丁美洲进入市场。奈诺沙星在美国完成了2期试验,并进行了3期临床试验。美国食品和药物管理局(FDA)已经批准了奈莫沙星合格传染病产品(QIDP)和社区获得性细菌性肺炎(CAP)和急性细菌性皮肤和皮肤结构感染(ABSSSI)的快速追踪标识。
-
默认
常备现货
-
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空选项
-
1-Cyclopropyl-7-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
-
BD248185221221-16-597%
-
¥3124.001g常备现货
-
3-Ethoxy-3-oxopropanoic acid
-
BD1293601071-46-197%
-
¥809.00500g常备现货
-
3-Bromo-2,6-difluorophenol
-
BD231023221220-99-198%
-
¥321.001g常备现货
-
Ethyl 1-cyclopropyl-7-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
-
BD330935221221-15-495%
-
¥4630.001g常备现货
-
1-Bromo-2,4-difluorobenzene
-
BD33332348-57-297%
-
¥80.00100g常备现货
-
Boc-Pyr-OH
-
BD2125153100-44-095%
-
¥467.00100g常备现货
-
2',4'-Difluoroacetophenone
-
BD33406364-83-097%
-
¥939.00500g常备现货
-
1-(tert-Butyl) 2-methyl (S)-5-oxopyrrolidine-1,2-dicarboxylate
-
BD17481108963-96-897%
-
¥30.0025g常备现货
-
tert-Butyl ((3S,5S)-5-methylpiperidin-3-yl)carbamate
-
BD119945951163-61-498%
-
¥3337.001g常备现货
-
7-((3S,5S)-3-Amino-5-methylpiperidin-1-yl)-1-cyclopropyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
-
BD01368570378746-64-698%
-
¥1202.001mg常备现货
-
1-(2,4-Difluoro-3-hydroxyphenyl)ethanone
-
BD458570951163-65-897%
-
¥8953.001g
-
2,4-Difluoro-3-methoxybenzoyl chloride
-
BD319678221221-11-095+%
-
¥1150.001g
-
1-Bromo-2,4-difluoro-3-methoxybenzene
-
BD219129221221-00-795+%
-
¥2769.001g
-
2,4-Difluoro-3-methoxybenzoic acid
-
BD5928178974-97-598%
-
¥185.001g
-
1-(2,4-Difluoro-3-methoxyphenyl)ethanone
-
BD66835373603-19-197%
-
¥1108.001g
-
2-(2,4-Difluorophenyl)-2-methyl-1,3-dioxolane
-
BD01119485882406-40-895%
-
¥455.001g
-
1-(tert-Butyl) 2-methyl (2S,4S)-4-methyl-5-oxopyrrolidine-1,2-dicarboxylate
-
BD01363795196394-48-698%
-
¥2577.00100mg